|Day Low/High||52.36 / 53.45|
|52 Wk Low/High||43.62 / 57.05|
Walgreens Boots Alliance, Clorox and Coca-Cola have produced reliable income streams through the best and worst of times.
Here's where traders could go long.
Perhaps the rally had been set up by the depth of the pressure placed on financial markets over the prior three days. Perhaps.
Here's why investors should take a closer look at AbbVie, Cardinal Health and Walgreens Boots Alliance -- and their solid dividends.
These recently downgraded names are displaying both quantitative and technical deterioration.
I have to admit that I deployed a good bit of cash on Tuesday, far more than I expected to during Thanksgiving week.
Stay tuned for my 2022 Tax Loss Selling Recovery Portfolio, which I'll roll out in early December.
While supply-chain constraints are a global problem, consumer-level inflation is not yet as broad a problem, or at least not evenly distributed.
RMPIA for the September-ending quarter is up .2%, outperforming most of the major market indexes. Let's dig in.
The 2021 Tax Loss Selling Recovery Portfolio gave up ground over the last month yet continues to outperform key indices.
Here I'll follow up on an article from last October and how the advice turned out.
Dan Aykroyd: "Jane you ignorant slut." Jane Curtain: "Dan, you pompous ass." - Saturday Night Live Yesterday, in our Comments Section, Subscriber JRinBerkeley thoughtfully presented his strong view suggesting that my drumbeat of "stagflation" repr...
Equity markets rallied out of an "almost deep" hole earlier in the day to finish the session close enough to unchanged. The S&P 500 tacked on 5 points or 0.13%, while the Nasdaq Composite picked up 15 points or 0.11%. The Dow Industrials closed down...
The 2021 Tax Loss Selling Recovery Portfolio gave up a bit of ground over the last month but still is solidly outperforming two major indices.
Walgreens Boots Alliance should benefit from an ageing population and increased demand for medications.
The 2021 Tax Loss Selling Recovery Portfolio gave ground over the last month but continues to perform far better than the S&P 500.
WBA reported top- and bottom-line beats in its fiscal third-quarter report and shares got whacked by Wall Street. Here's why I see a catch-up move ahead.
Over time the portfolio has provided some fairly solid results, and so far, so good with this year's version.
We didn't see much wild rotation, but the Russell 2000 did outperform, and the negative action could prove good from a technical standpoint.
Here's a followup from my May 2020 stock picks and how they played out during the pandemic year.
Let look at a 1-2-3 strategy to make money, using Berry and CVS as examples.
The 2021 Tax Loss Selling Recovery Portfolio didn't do much in April but is soundly beating the market six months after inception.
Here's why the tech giant stumbled after earnings and what I see as better investments.
Both stocks have been underperformers.
Walgreens Boots Alliance looks right now like Target did at its 2017 low. Here's what that means for investors.
The 2021 Tax Loss Selling Recovery Portfolio is killing it, which makes it tempting to shut it down and harvest the profits, but we'll let the experiment roll on.
Word is that Biden will introduce the first part of two spending plans that will likely cost anywhere from $2 trillion to $2.5 trillion over eight years.